GenetiSure Cancer and Postnatal Arrays - Human Microarrays - Agilent Technology

Whether conducting cancer research or postnatal genetic studies, Agilent GenetiSure CGH+SNP microarrays are designed to deliver comprehensive and reliable genomic analysis. These advanced microarrays enable simultaneous detection of copy number variations (CNVs) and copy-neutral aberrations, supporting accurate identification of clinically significant genomic changes.

The GenetiSure Cancer Research CGH+SNP microarray specifically targets cancer-associated regions of the genome curated from the COSMIC and Cancer Gene Census (CGC) databases. With validated loss of heterozygosity (LOH) detection down to 2.5 Mb resolution, the array ensures that critical genomic alterations are detected with confidence, minimizing the risk of missing important aberrations in oncology research.

For postnatal research applications, the GenetiSure Postnatal Research CGH+SNP microarray enables simultaneous detection of copy number changes and copy-neutral events with high resolution. The inclusion of exon-centric probes enhances the identification of genomic aberrations linked to intellectual disabilities and congenital anomalies, providing deeper insight into complex genetic conditions.

By combining targeted probe design, high-resolution detection, and dual CGH+SNP analysis, Agilent GenetiSure microarrays support accurate, efficient, and meaningful cytogenetic research outcomes.

Labindia Instruments is the authorised dealer in India for Agilent Technologies, offering trusted access and support for advanced genomic research solutions.